Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer.
暂无分享,去创建一个
R. Rad | D. Saur | A. Schnieke | A. Kind | D. Alessi | R. Schmid | C. Michalski | I. Esposito | M. Baccarini | G. Schneider | B. Seidler | S. Eser | Sabine Klein | Lena Rad | A. Schlitter | B. Kong | M. Hieber | A. Arbeiter | K. Gottschalk | M. Messer | Nina Reiff | M. Dobler
[1] M. Barbacid,et al. EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma. , 2012, Cancer cell.
[2] Jens T Siveke,et al. EGF receptor is required for KRAS-induced pancreatic tumorigenesis. , 2012, Cancer cell.
[3] Laura M. Heiser,et al. A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinoma. , 2012, Cancer discovery.
[4] D. Saur,et al. Production of avian retroviruses and tissue-specific somatic retroviral gene transfer in vivo using the RCAS/TVA system , 2012, Nature Protocols.
[5] R. Hruban,et al. Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer , 2012, Oncogene.
[6] S. Durinck,et al. Conditional activation of Pik3caH1047R in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations , 2012, Oncogene.
[7] H. Höfler,et al. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues , 2012, The Journal of pathology.
[8] A. Rustgi,et al. Pancreatic ductal cells in development, regeneration, and neoplasia. , 2011, The Journal of clinical investigation.
[9] J. Meyerhardt,et al. Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers. , 2011, The Journal of clinical investigation.
[10] J. Kleeff,et al. Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinoma. , 2011, Neoplasia.
[11] D. Bar-Sagi,et al. RAS oncogenes: weaving a tumorigenic web , 2011, Nature Reviews Cancer.
[12] M. Sliwkowski,et al. Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2–Positive Cancer , 2011, Clinical Cancer Research.
[13] P. Mazur,et al. Early requirement of Rac1 in a mouse model of pancreatic cancer. , 2011, Gastroenterology.
[14] D. Tuveson,et al. C-Raf is required for the initiation of lung cancer by K-Ras(G12D). , 2011, Cancer discovery.
[15] Gerald C. Chu,et al. PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network. , 2011, Cancer discovery.
[16] G. Mills,et al. Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and -independent mechanisms , 2011, Nature Medicine.
[17] A. Meining,et al. In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging , 2011, Proceedings of the National Academy of Sciences.
[18] M. Barbacid,et al. c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma. , 2011, Cancer cell.
[19] Rugang Zhang,et al. Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis. , 2011, Molecular cell.
[20] S. Egan,et al. Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation. , 2011, Cancer research.
[21] Julian Downward,et al. RAS Interaction with PI3K: More Than Just Another Effector Pathway. , 2011, Genes & cancer.
[22] F. Real,et al. Adult pancreatic acinar cells dedifferentiate to an embryonic progenitor phenotype with concomitant activation of a senescence programme that is present in chronic pancreatitis , 2010, Gut.
[23] M. Hebrok,et al. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma , 2010, Nature Reviews Cancer.
[24] R. DePinho,et al. PI3 Kinase Signals BCR-Dependent Mature B Cell Survival , 2009, Cell.
[25] J. J. Westmoreland,et al. Pdk1 activity controls proliferation, survival, and growth of developing pancreatic cells. , 2009, Developmental biology.
[26] Pixu Liu,et al. Targeting the phosphoinositide 3-kinase pathway in cancer , 2009, Nature Reviews Drug Discovery.
[27] Jeffrey A. Engelman,et al. Targeting PI3K signalling in cancer: opportunities, challenges and limitations , 2009, Nature Reviews Cancer.
[28] D. Saur,et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. , 2009, Gastroenterology.
[29] David Allard,et al. Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.
[30] T. Jacks,et al. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase , 2009, Nature Protocols.
[31] Ralph Weissleder,et al. Effective Use of PI3K and MEK Inhibitors to Treat Mutant K-Ras G12D and PIK3CA H1047R Murine Lung Cancers , 2008, Nature Medicine.
[32] A. Meining,et al. Highly sensitive detection of early‐stage pancreatic cancer by multimodal near‐infrared molecular imaging in living mice , 2008, International journal of cancer.
[33] D. Saur,et al. RCAS-mediated retroviral gene delivery: a versatile tool for the study of gene function in a mouse model of pancreatic cancer. , 2008, Human gene therapy.
[34] D. Saur,et al. A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors , 2008, Proceedings of the National Academy of Sciences.
[35] Holger Gerhardt,et al. Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration , 2008, Nature.
[36] Manuel Hidalgo,et al. Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer. , 2008, Cancer research.
[37] L. Luo,et al. A global double‐fluorescent Cre reporter mouse , 2007, Genesis.
[38] G. Stamp,et al. Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice , 2007, Cell.
[39] D. Saur,et al. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells. , 2007, Cancer research.
[40] Friedrich Paulsen,et al. Ptf1a is essential for the differentiation of GABAergic and glycinergic amacrine cells and horizontal cells in the mouse retina , 2007, Development.
[41] M. Barbacid,et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. , 2007, Cancer cell.
[42] Y. Kido,et al. Ablation of PDK1 in pancreatic β cells induces diabetes as a result of loss of β cell mass , 2006, Nature Genetics.
[43] Ralph Weissleder,et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[44] Li Zhao,et al. Oncogenic PI3K deregulates transcription and translation , 2005, Nature Reviews Cancer.
[45] R. DePinho,et al. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. , 2005, Cancer cell.
[46] S. Leach,et al. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates , 2005, Development.
[47] R. Hruban,et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.
[48] M. Schwaiger,et al. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. , 2005, Gastroenterology.
[49] C. Haglund,et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry , 2005, Gut.
[50] R. DePinho,et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.
[51] E. Petricoin,et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.
[52] A. Prescott,et al. Essential role of PDK1 in regulating cell size and development in mice , 2002, The EMBO journal.
[53] Lewis C Cantley,et al. The phosphoinositide 3-kinase pathway. , 2002, Science.
[54] A. Berns,et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer , 2001, Nature Genetics.
[55] E. Wagner,et al. Protective Role of Raf-1 in Salmonella-Induced Macrophage Apoptosis , 2001, The Journal of experimental medicine.
[56] P. Cohen,et al. Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. , 1999, The Biochemical journal.
[57] P. Cohen,et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.
[58] E. Diamandis,et al. Pancreatic cancer. , 2013, Clinical chemistry.
[59] D. Alessi,et al. The nuts and bolts of AGC protein kinases , 2010, Nature Reviews Molecular Cell Biology.
[60] Y. Kido,et al. Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass. , 2006, Nature genetics.
[61] R. Hruban,et al. Pancreatic cancer in mice and man: the Penn Workshop 2004. , 2006, Cancer research.